Tuberculosis and serious infusion reactions in Japanese patients with rheumatoid arthritis: Results from the post marketing surveillance trial.

被引：0
|
作者：
Dabbous, Omar
Tatsuki, Yoshihiko
Rahman, Mirza I.
Gilmer, Keith
Arjunji, Ramesh
Thompson, Heidi
Togo, Masanori
Tang, Boxiong
Suzuki, Toshikazu
机构：
[1] Tanabe Seiyaku Co Ltd, Osaka, Japan
[2] Centocor Inc, Horsham, PA USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S422 / S422
页数：1
相关论文
共 50 条
  • [31] Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
    Gerd R. Burmester
    Laura C. Coates
    Stanley B. Cohen
    Yoshiya Tanaka
    Ivana Vranic
    Edward Nagy
    Irina Lazariciu
    All-shine Chen
    Kenneth Kwok
    Lara Fallon
    Cassandra Kinch
    Rheumatology and Therapy, 2023, 10 : 1255 - 1276
  • [32] Long-term tolerability and effectiveness of raltegravir in Japanese patients: Results from post-marketing surveillance
    Kuroishi, Naho
    Watananbe, Asuka
    Sakuma, Ryuta
    Ruzicka, Daniel J.
    Hara, Mitsuyoshi
    PLOS ONE, 2019, 14 (01):
  • [33] EFFECT OF THERMOFORMABLE ORTHOSES ON FOOT FUNCTION IN RHEUMATOID ARTHRITIS PATIENTS: PRELIMINARY RESULTS FROM AN OPEN CLINICAL TRIAL.
    Aachari, I.
    Rkain, H.
    Safaa, F.
    Benzakour, L.
    Latifa, T.
    Alami, N.
    Guieu, R.
    Jammes, Y.
    Hajjaj-Hassouni, N.
    Allali, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 907 - 908
  • [34] Genetic Predictors of Methotrexate Efficacy and Toxicity in Early Rheumatoid Arthritis: Results From the Treatment of Early Aggressive Rheumatoid Arthritis Trial.
    Aslibekyan, Stella
    Brown, Elizabeth
    Reynolds, Richard J.
    Redden, David T.
    Morgan, Sarah L.
    Baggott, Joseph
    Sha, Jin
    Moreland, Larry W.
    O'Dell, James R.
    Curtis, Jeffrey R.
    Bridges, S. Louis, Jr.
    Arnett, Donna K.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S431 - S431
  • [35] Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance
    Takagi, Michiaki
    Atsumi, Tatsuya
    Matsuno, Hiroaki
    Tamura, Naoto
    Fujii, Takao
    Okamoto, Nami
    Takahashi, Nobunori
    Nakajima, Atsuo
    Nakajima, Ayako
    Tsujimoto, Naoto
    Nishikawa, Atsushi
    Ishii, Taeko
    Takeuchi, Tsutomu
    Kuwana, Masataka
    MODERN RHEUMATOLOGY, 2023, 33 (04) : 647 - 656
  • [36] Celecoxib in the symptomatic treatment of active osteo- or rheumatoid arthritis: results of a post-marketing surveillance study
    Wigand, R
    Wehling, M
    Brauer, HG
    Stridde, E
    Vergin, H
    May, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (21) : 1188 - 1192
  • [37] Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
    Gerd R. Burmester
    Laura C. Coates
    Stanley B. Cohen
    Yoshiya Tanaka
    Ivana Vranic
    Edward Nagy
    Irina Lazariciu
    All-shine Chen
    Kenneth Kwok
    Lara Fallon
    Cassandra Kinch
    Rheumatology and Therapy, 2024, 11 (1) : 221 - 222
  • [38] Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance
    Harigai, Masayoshi
    Ishiguro, Naoki
    Inokuma, Shigeko
    Mimori, Tsuneyo
    Ryu, Junnosuke
    Takei, Syuji
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Takasaki, Yoshinari
    Yamanaka, Hisashi
    Yoshizawa, Yuri
    Chineni, Ichino
    Nakao, Toru
    Koike, Takao
    MODERN RHEUMATOLOGY, 2019, 29 (05) : 747 - 755
  • [39] Safety and effectiveness of tofacitinib in Korean adult patients with rheumatoid arthritis: A post-marketing surveillance study
    Ju, Ji Hyeon
    Sung, Yoon-Kyoung
    Jo, Joo-young
    Jeon, Ja-Young
    Yoo, Hyun-Jeong
    Lee, Eun Bong
    MODERN RHEUMATOLOGY, 2023, 33 (06) : 1087 - 1096
  • [40] Aflibercept with FOLFIRI in Japanese patients with metastatic colorectal cancer: results of a post-marketing surveillance
    Jun Watanabe
    Tetsuji Terazawa
    Shiho Yamane
    Hirotaka Kazama
    Hiroyuki Uetake
    Takayuki Yoshino
    International Journal of Clinical Oncology, 2023, 28 : 130 - 138
12345